Koziczak-Holbro, M., Rigel, D. F., Dumotier, B., Sykes, D. A., Tsao, J., Nguyen, N. H., Bösch, J., Jourdain, M., Flotte, L., Adachi, Y., Kiffe, M., Azria, M., Fairhurst, R. A., Charlton, S. J., Richardson, B. P., Lach-Trifilieff, E., Glass, D. J., Ullrich, T., & Hatakeyama, S. (2019). Pharmacological characterization of a novel 5-hydroxybenzothiazolone-derived b2-adrenoceptor agonist with functional selectivity for anabolic effects on skeletal muscle resulting in a wider cardiovascular safety window in preclinical studies. Journal of Pharmacology and Experimental Therapeutics, 369(2), 188-199. https://doi.org/10.1124/jpet.118.255307